Adalimumab Biosimilar Litigation: Sandoz’s settlement with AbbVie
Sandoz, a Novartis division and the global leader in biosimilars, announced a global resolution of all intellectual property (IP) related litigation with... Read More
Case Study – Quick Look up at DCGI approval of Lundbeck’s Brintellix
Posted on15 Oct 2018
TagsBrintellix, CDSCO, codevelopment deal in pharma, comarketing deal in pharma, copromotion deal in pharma, DCGI, Lundbeck, vortioxetine
Comments0
Lundbeck India Private Limited (LIPL) announces the launch of Brintellix (vortioxetine) in India for the treatment of patients suffering from major depressive... Read More
Eyevance Pharmaceuticals Acquires Worldwide Rights to NEXAGON®
Posted on04 Oct 2018
Comments0
Eyevance Pharmaceuticals, a Fort Worth-based pharmaceutical company committed to developing and commercializing innovative and impactful ophthalmic products, announced a worldwide licensing agreement... Read More
Case Study: USFDA The Limited Population Pathway and approval of Arikayce
The US Food and Drug Administration late Friday granted accelerated approval of Arikayce (amikacin liposome inhalation suspension), developed by US biotech Insmed,... Read More
Dr. Reddy’s sells Cloderm cream to EPI Health
Posted on03 Oct 2018
Comments0
Dr. Reddy’s Laboratories’ wholly owned U.S. subsidiary Promius Pharma has sold rights of Cloderm (clocortolone pivalate) cream and its authorised generic to... Read More
DRL to disinvest antibiotics plant to Abu Dhabi-based Neopharma
Dr Reddy’s Laboratories on Monday announced the closure of the sale of its antibiotic manufacturing facility and related assets in Bristol, Tennessee... Read More
Case Study: Product Recall due to labeling error
Posted on03 Oct 2018
Tagsclass i recall, FDA's role in product recall, medicine labeling, Product Recall, Produt recall, What is class i Recall
Comments0
Endo Pharmaceuticals Inc, is voluntarily recalling two lots of Robaxin (methocarbamol tablets, USP) 750mg tablets 100 count bottle pack to the consumer... Read More